ProfileGDS5678 / 1425142_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 100% 99% 99% 99% 100% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 113.446699
GSM967853U87-EV human glioblastoma xenograft - Control 213.371399
GSM967854U87-EV human glioblastoma xenograft - Control 313.38299
GSM967855U87-EV human glioblastoma xenograft - Control 413.114399
GSM967856U87-EV human glioblastoma xenograft - Control 513.116599
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 113.505199
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 213.6088100
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 313.082499
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 413.175599
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 113.454199
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 213.5346100
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 313.371499
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 413.40199
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 513.2699